Genelux CORP (GNLX) 13F Filings: Institutional Buyers & Sellers (Q2 2026)

GNLX ranks #5244 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

74 institutions disclose a position in GNLX, but none treat it as a major bet — even Woodward Diversified Capital, LLC, its most concentrated holder, allocates just 3.0% of its own portfolio to it.

Bleichroeder LP has added to its GNLX position for two straight quarters, increasing it by $1.0M to reach $4.2M today.

Barclays PLC has trimmed its GNLX position for two straight quarters, cutting it by $359.4K while still holding $801.0.

GNLX is down 1.7% today, but institutions show net buying of $2.3M this quarter — a divergence between today's price move and the underlying institutional flow.

GNLX reported a net loss of $35.6M over the trailing twelve months.

• Not yet profitable — net loss of $35.6M over the trailing twelve months
• Revenue declined 95.3% year over year
• Net income declined year over year, from -$30.4M to -$35.6M
• Operating cash flow was negative, using $25.3M in cash
• Current ratio of 2.43x — enough short-term assets to cover short-term liabilities
• Liabilities run 196.92x equity — a highly leveraged balance sheet worth noting